Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Ovid Therapeutics (OVID) Return on Assets (2020 - 2025)

Ovid Therapeutics' Return on Assets history spans 6 years, with the latest figure at 0.16% for Q4 2025.

  • For Q4 2025, Return on Assets rose 11.0% year-over-year to 0.16%; the TTM value through Dec 2025 reached 0.16%, up 11.0%, while the annual FY2025 figure was 0.14%, 8.0% up from the prior year.
  • Return on Assets reached 0.16% in Q4 2025 per OVID's latest filing, up from 0.51% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.73% in Q1 2021 to a low of 0.51% in Q3 2025.
  • Average Return on Assets over 5 years is 0.15%, with a median of 0.34% recorded in 2023.
  • Peak YoY movement for Return on Assets: skyrocketed 158bps in 2021, then crashed -109bps in 2022.
  • A 5-year view of Return on Assets shows it stood at 0.61% in 2021, then plummeted by -155bps to 0.34% in 2022, then dropped by -15bps to 0.39% in 2023, then surged by 30bps to 0.27% in 2024, then skyrocketed by 40bps to 0.16% in 2025.
  • Per Business Quant, the three most recent readings for OVID's Return on Assets are 0.16% (Q4 2025), 0.51% (Q3 2025), and 0.48% (Q2 2025).